WeVote
Log In

Bill

Bill

SD 3982

MassHealth Direct Negotiations Report

194th Legislature (2025-2026)

MassHealth must publicly report its direct price negotiation efforts, including strategies, costs, potential savings, methodologies, timelines, and outcomes.

Placed on file
0
WeVote Research Nonpartisan
Bill Summary · SD 3982

Summary of Bill SD 3982 (MassHealth Direct Negotiations Report)

Jurisdiction: Massachusetts

Session: 194th

Status: Placed on file (as of 2026-06-11)

Purpose and intent

MassHealth Direct Negotiations Report is designed to require the timely preparation, submission, and public sharing of findings related to direct price negotiations for MassHealth (Massachusetts Medicaid) services and prescription drugs. The bill aims to enhance transparency and accountability around direct negotiation efforts and to provide policymakers, stakeholders, and the public with information on costs, methodologies, and potential savings.

Key provisions and changes

  • Reporting Requirement: The bill mandates the creation of a formal report detailing MassHealth’s direct negotiation activities. This includes strategies, assumptions, and outcomes associated with negotiating rates or prices directly with providers, hospitals, or pharmaceutical manufacturers.
  • Scope of Negotiations: The report would encompass direct negotiation efforts beyond standard managed care rate setting, focusing on pursuing favorable pricing through direct engagements with suppliers and providers.
  • Cost and Savings Analysis: The document must include estimated and actual costs, potential savings, and financial impact on MassHealth expenditures resulting from direct negotiation efforts.
  • Methodology Disclosure: The report should outline the methodologies and criteria used in negotiations, including any benchmarks, comparison sets, and the rationale for negotiated terms.
  • Timeline and Milestones: The bill requires a timeline for ongoing negotiations and anticipated milestones, highlighting short-, medium-, and long-term targets.
  • Public Accessibility: The findings and data from the report would be made publicly available, ensuring transparency for beneficiaries, providers, and taxpayers.
  • Stakeholder Input: The process may include opportunities for stakeholder input or review, potentially involving consumer groups, providers, and other interested parties.

Who/what would be affected

  • MassHealth Program: The primary beneficiary is the MassHealth system, as it would implement and report on direct negotiation activities.
  • MassHealth Beneficiaries: Potential indirect beneficiaries through greater transparency and potential cost savings that could influence benefits or coverage decisions.
  • Providers and Manufacturers: Pharmaceutical companies, hospitals, and other healthcare providers engaged in direct negotiation with MassHealth would be subject to scrutiny, data disclosure, and compliance with reporting requirements.
  • State Agencies and Legislators: Responsible for oversight, monitoring progress, and using the report to inform policy decisions and budget planning.

Procedural and timeline aspects

  • Placement on File: As of 2026-06-11, the bill has been placed on file, indicating it has been officially filed and referred to appropriate committees or awaiting further action. This status typically means no immediate enactment but allows continued consideration, hearings, or amendments.
  • Reporting Cadence: The bill outlines a requirement for ongoing or periodic reporting, with a defined schedule for updates (e.g., annual or biannual reports) and a final or comprehensive report at specified intervals.
  • Compliance and Enforcement: While not detailed here, the bill would ordinarily include provisions on compliance, data sharing standards, and potential remedies for noncompliance or misreporting.

Potential impact and considerations

  • Transparency and Accountability: Enhanced visibility into MassHealth’s direct negotiation efforts could improve public trust and allow for informed policymaking.
  • Budgetary Implications: Detailed cost/savings analyses could influence state budget decisions and long-term fiscal planning for MassHealth.
  • Negotiation Dynamics: Public disclosure of negotiation methodologies and timelines may affect negotiating leverage and stakeholder strategies.
  • Beneficiary Impact: If direct negotiations yield favorable pricing, downstream effects could include more stable or expanded benefits, though the bill focuses on reporting rather than guaranteeing specific price outcomes.

If you’d like, I can tailor this summary to emphasize specific sections (e.g., methodology, stakeholder process, or data privacy considerations) or compare it to similar reporting requirements in other states.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.